DSpace Repository

Association of implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa

Show simple item record

dc.contributor.author Ayieko, James
dc.contributor.author Sang, Norton
dc.contributor.author Kabami, Jane
dc.contributor.author A Bukusi, Elizabeth
dc.date.accessioned 2021-07-08T08:44:43Z
dc.date.available 2021-07-08T08:44:43Z
dc.date.issued 2017-06-06
dc.identifier.uri http://ir.mu.ac.ke:8080/jspui/handle/123456789/4792
dc.description.abstract IMPORTANCE Antiretroviral treatment (ART) is now recommended for all HIV-positive persons. UNAIDS has set global targets to diagnose 90% of HIV-positive individuals, treat 90% of diagnosed individuals with ART, and suppress viral replication among 90% of treated individuals, for a population-level target of 73%of all HIV-positive persons with HIV viral suppression. OBJECTIVE To describe changes in the proportions of HIV-positive individuals with HIV viral suppression, HIV-positive individuals who had received a diagnosis, diagnosed individuals treated with ART, and treated individuals with HIV viral suppression, following implementation of a community-based testing and treatment program in rural East Africa. DESIGN, SETTING, AND PARTICIPANTS Observational analysis based on interim data from 16 rural Kenyan (n = 6) and Ugandan (n = 10) intervention communities in the SEARCH Study, an ongoing cluster randomized trial. Community residents who were 15 years or older (N = 77 774) were followed up for 2 years (2013-2014 to 2015-2016). HIV serostatus and plasma HIV RNA level were measured annually at multidisease health campaigns followed by home-based testing for nonattendees. All HIV-positive individuals were offered ART using a streamlined delivery model designed to reduce structural barriers, improve patient-clinician relationships, and enhance patient knowledge and attitudes about HIV. MAIN OUTCOMES AND MEASURES Primary outcomewas viral suppression (plasma HIV RNA<500 copies/mL) among all HIV-positive individuals, assessed at baseline and after 1 and 2 years. Secondary outcomes included HIV diagnosis, ART among previously diagnosed individuals, and viral suppression among those who had initiated ART. RESULTS Among 77 774 residents (male, 45.3%; age 15-24 years, 35.1%), baseline HIV prevalence was 10.3%(7108 of 69 283 residents). The proportion of HIV-positive individuals with HIV viral suppression at baseline was 44.7%(95%CI, 43.5%-45.9%; 3464 of 7745 residents) and after 2 years of intervention was 80.2%(95%CI, 79.1%-81.2%; 5666 of 7068 residents), an increase of 35.5 percentage points (95%CI, 34.4-36.6). After 2 years, 95.9%of HIV-positive individuals had been previously diagnosed (95%CI, 95.3%-96.5%; 6780 of 7068 residents); 93.4%of those previously diagnosed had received ART (95%CI, 92.8%-94.0%; 6334 of 6780 residents); and 89.5%of those treated had achieved HIV viral suppression (95%CI, 88.6%-90.3%; 5666 of 6334 residents). CONCLUSIONS AND RELEVANCE Among individuals with HIV in rural Kenya andUganda, implementation of community-based testing and treatmentwas associated with an increased proportion of HIV-positive adults who achieved viral suppression, along with increased HIV diagnosis and initiation of antiretroviral therapy. In these communities, the UNAIDS populationlevel viral suppression targetwas exceeded within 2 years after programimplementation. en_US
dc.language.iso en en_US
dc.publisher American Medical Association en_US
dc.subject Universal Testing en_US
dc.subject HIV Diagnosis en_US
dc.subject Antiretroviral Therapy en_US
dc.subject viral suppression en_US
dc.title Association of implementation of a universal testing and treatment intervention with HIV diagnosis, receipt of antiretroviral therapy, and viral suppression in East Africa en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account